'60 Leaders' is an initiative that brings together diverse views from global thought leaders on a series of topics – from innovation and artificial intelligence to social media and democracy. It is created and distributed on principles of open collaboration and knowledge sharing. Created by many, offered to all.
ABOUT 60 LEADERS
'60 Leaders on Artificial Intelligence' brings together unique insights on the topic of Artificial Intelligence - from the latest technical advances to ethical concerns and risks for humanity. The book is organized into 17 chapters - each addressing one question through multiple answers reflecting a variety of backgrounds and standpoints. Learn how AI is changing how businesses operate, how products are built, and how companies should adapt to the new reality. Understand the risks of AI and what should be done to protect individuals and humanity. View the leaders.
'60 Leaders on Innovation' is the book that brings together unique insights and ‘practical wisdom’ on innovation. The book is organized into 22 chapters, each presenting one question and multiple answers from 60 global leaders. Learn how innovative companies operate and how to adopt effective innovation strategies. Understand how innovation and experimentation methods blend with agile product development. Get insights from the experts on the role of the C-Suite for innovation. Discover ways that Innovation can help humanity solve big problems like climate change.
What is the most impressive task that AI can accomplish today?
AI is here to stay, and we must agree that the hype is now over according to the steady growth of investment in AI, spanning virtually all industries and sectors along with their digital transformation. The tasks AI can accomplish today are almost infinite as per our human unbounded capacity to think and dream. Still, the financial payoff has not achieved the spectacular promised results due to a mix of failures and successes almost all enterprises and verticals have experienced by adopting AI. Regrettably, many companies have discovered that having large amounts of data is not enough to secure successful outcomes from AI. And many more have paid high bills aiming at addressing wrongly stated problem statements, often too broadly defined. Without a delimited and well-defined purpose, no ROI should be possible and AI technology, whether Machine Learning or Deep Learning, is not an exception. But the resilience of first AI adopters will end up rewarding the big majority of them thanks to their unique learnings gathered across their AI transition journey.
Currently, Machine Learning and Deep learning are being intensively used in research with promising results, particularly Neural Networks as they dramatically accelerate computationally intensive processes, e.g., drug discovery . Research benefits from a high degree of liberty that is hardly seen in other areas, thus being the ideal candidate for investing in powerful, though complex, Neural Networks architectures – only limited by budget allocation capacity. On the other end, there are all those industries that are subject to heavy regulations for which interpretability of Deep Learning models is a problem. Thus, following the example of drug discovery, the adoption of Neural Networks for the subsequent manufacture of these new drugs is a no go right now, according to Good Manufacturing Practices regulation in Pharma and Biotechnology.
Moving away from highly regulated industries, AI has already demonstrated its feasibility to generate potential value from the use of pattern recognition (people’s faces, sign language, etc.) to fully autonomous equipment (self-driven cars, home vacuum cleaners, etc.) thanks to Computer Vision using Convolutional Neural Networks; and from voice-led instructions to activate appliances, select and execute tasks, to text mining or simultaneous translation using Natural Language Processing technology. No doubt Deep Learning is the field of AI that delivers the closest Human-to-Machine and Machine-to-Machine interactions without simply mimicking Human behaviour as Robotics Process Automation does from a collection of pre-set rules.
For sure, we can all look astonished at the performance of a fully autonomous car, but AI still has a lot to do to make the self-driving experience fully secure, and again regulation has a lot to say. Then maybe simple yet irrelevant things like telling Siri that you feel happy, and it selects one of your most-loved songs to play becomes impressive as we are absolutely unconscious of the swift connection we have built over AI.
Still, to me, the most impressive task that AI can accomplish is yet to come and it will deal with Human health, and more precisely, the diagnosis and prognosis of patients’ life-threatening conditions. The challenge is paramount as there are no two equal persons in the world – yes, even identical twins have genetic differences . Additionally, any intervention, such as any initiated treatment, severely biases patients’ health data. Hence, a predictive model aiming at diagnosing, for instance, the risk of metastases in breast cancer patients, is subject to an excessive number of factors (variables aka features) that dramatically reduces any subset of available patients to an insufficient number of samples that could be decently used for model training. And here the word ‘decently’ has all connotations: legal, medical, social, cultural, ethical, and economical. How to deal with data privacy and data protection is just an example of issues that easily prompts our minds regarding patients and healthcare institutions, data controllers, and data processors. But these issues are all inherent to AI and they must be addressed in full alignment of all healthcare stakeholders, a common will, and a titanic effort.